olodaterol/tiotropium (Stiolto Respimat)
Jump to navigation
Jump to search
Indications
Dosage
- once-daily oral inhalation spray
Adverse effects
More general terms
Components
References
- ↑ Lowes R FDA Approves Stiolto Respimat for COPD Medscape Oncology. May 26, 2015 http://www.medscape.com/viewarticle/845398
Boehringer Ingelheim PR Newswire. May 26, 2015 FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD. http://www.prnewswire.com/news-releases/fda-approves-boehringer-ingelheims-stiolto-respimat-inhalation-spray-as-once-daily-maintenance-treatment-for-copd-300088485.html